What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling

Matthew Evison, Ross Maconachie, Toby Mercer, Caitlin H. Daly, Nicky J. Welton, Shahzeena Aslam, Doug West, Neal Navani

Source: ERJ Open Res, 9 (2) 00299-2022; 10.1183/23120541.00299-2022
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Matthew Evison, Ross Maconachie, Toby Mercer, Caitlin H. Daly, Nicky J. Welton, Shahzeena Aslam, Doug West, Neal Navani. What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling. ERJ Open Res, 9 (2) 00299-2022; 10.1183/23120541.00299-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.